In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease

Journal of Comparative Neurology

Volumn 521, Issue 18, 2013, Pages 4300-4317

  Solodkin, Ana ^a   Chen, E Elinor ^a   Van Hoesen, Gary W ^b   Heimer, Lennart ^c   Shereen, Ahmed ^a   Kruggel, Frithjof ^d   Mastrianni, James ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

Author keywords

AD conversion; DTI; Limbic; MCI; Microstructure; Perforant pathway

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ANTERIOR POSTERIOR AXIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISCRIMINANT ANALYSIS; DISEASE COURSE; EARLY DIAGNOSIS; FRACTIONAL ANISOTROPY; HIGH RISK PATIENT; HUMAN; IN VIVO STUDY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PARAHIPPOCAMPAL GYRUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; WHITE MATTER LESION;

AD CONVERSION; DTI; LIMBIC; MCI; MICROSTRUCTURE; PERFORANT PATHWAY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MILD COGNITIVE IMPAIRMENT; NERVE FIBERS, MYELINATED; PARAHIPPOCAMPAL GYRUS;

EID: 84886709433     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23418     Document Type: Article

References (129)

1. Acosta-Cabronero J, Williams GB, Pengas G, Nestor PJ. 2010. Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 133:529-539.
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. 2011. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:270-279.
3. Almkvist O, Axelman K, Basun H, Wahlund LO, Lannfelt L. 2002. Conversion from preclinical to dinical stage of Alzheimer's disease as shown by decline of cognitive function in carriers of the Swedish APP-mutation. J Neural Transmiss Suppl, 117-125.
4. Amaral DG, Cowan WM. 1980. Subcortical afferents to the hippocampal formation in the monkey. J Comp Neurol 189:573-591.
5. Amaral DG, Price JL. 1984. Amygdalo-cortical projections in the monkey (Macaca fascicularis). J Comp Neurol 230:465-496.
6. Amaral DG, Insausti R, Cowan WM. 1987. The entorhinal cortex of the monkey: I. Cytoarchitectonic organization. J Comp Neurol 264:326-355.
7. Arenaza-Urquijo EM, Bosch B, Sala-Llonch R, Sole-Padulles C, Junque C, Fernandez-Espejo D, Bargallo N, Rami L, Molinuevo JL, Bartres-Faz D. 2010. Specific anatomic associations between white matter integrity and cognitive reserve in normal and cognitively impaired elders. Am J Geriatr Psychiatry 19:33-42.
8. Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW. 1991. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1:103-116.
9. Assaf Y, Cohen Y. 2000. Assignment of the water slow-diffusing component in the central nervous system using q-space diffusion MRS: implications for fiber tract imaging. Magn Reson Med 43:191-199.
10. Augustinack JC, Helmer K, Huber KE, Kakunoori S, Zollei L, Fischl B. 2010. Direct visualization of the perforant pathway in the human brain with ex vivo diffusion tensor imaging. Front Hum Neurosci 4:42.
11. Baclet-Roussel C, Ankri J, Ergis AM. 2010. [Contribution of various MRI techniques to the characterization of mild cognitive impairment]. Psychol Neuropsychiatr Vieil 8:53-64.
12. Basser PJ, Pierpaoli C. 1996. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 111:209-219.
13. Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, Matthews PM, Brady JM, Smith SM. 2003. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med 50:1077-1088.
14. Benedict RHB, Schretlen D, Groniger L, Dobraski M, Shpritz B. 1996. Revision of the brief Visuospatial Memory test: studies of normal performance, reliability, and validity. Psychol Assess 8:145-153.
15. Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junque C, Sole-Padulles C, Pena-Gomez C, Bargallo N, Molinuevo JL, Bartres-Faz D. 2010. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging 33:61-74.
16. Braak H, Braak E. 1997a. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357.
17. Braak H, Braak E. 1997b. Staging of Alzheimer-related cortical destruction. Int Psychogeriatry 9(Suppl 1):257-261; discussion 269-272.
18. Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, Huang SC, Barrio JR, Ercoli LM, Siddarth P, Satyamurthy N, Liu J, Toga AW, Bookheimer SY, Small GW, Thompson PM. 2010. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol Aging 31:1669-1678.
19. Buchanan D. 2009. Review: long-term annual conversion rate to dementia was 3.3% in elderly people with mild cognitive impairment. Evidence-Based Nursing 12:87.
20. Butts T, Chaplin N, Wingate RJ. 2011. Can clues from evolution unlock the molecular development of the cerebellum? Mol Neurobiol 43:67-76.
21. Chen TF, Lin CC, Chen YF, Liu HM, Hua MS, Huang YC, Chiu MJ. 2009. Diffusion tensor changes in patients with amnesic mild cognitive impairment and various dementias. Psychiatr Res 173:15-21.
22. Cherubini A, Peran P, Spoletini I, Di Paola M, Di Iulio F, Hagberg GE, Sancesario G, Gianni W, Bossu P, Caltagirone C, Sabatini U, Spalletta G. 2010. Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J Alzheimers Dis 19:1273-1282.
23. Chetelat G, Eustache F, Viader F, De La Sayette V, Pelerin A, Mezenge F, Hannequin D, Dupuy B, Baron JC, Desgranges B. 2005. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 11:14-25.
24. Chrobak JJ, Amaral DG. 2007. Entorhinal cortex of the monkey: VII. Intrinsic connections. J Comp Neurol 500:612-633.
25. Chubb C, Inagaki Y, Sheu P, Cummings B, Wasserman A, Head E, Cotman C. 2006. BioVision: an application for the automated image analysis of histological sections. Neurobiol Aging 27:1462-1476.
26. Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Arora A, Carpenter AP, Flitter ML, Joshi AD, Krautkramer MJ, Lu M, Mintun MA, Skovronsky DM, Group A-AS. 2012. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study. Lancet Neurol 11:669-678.
27. Damoiseaux JS, Smith SM, Witter MP, Sanz-Arigita EJ, Barkhof F, Scheltens P, Stam CJ, Zarei M, Rombouts SA. 2009. White matter tract integrity in aging and Alzheimer's disease. Hum Brain Mapp 30:1051-1059.
28. Davatzikos C, Xu F, An Y, Fan Y, Resnick SM. 2009. Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain 132:2026-2035.
29. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ. 2010. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32:19-27.
30. de Crespigny AJ, Marks MP, Enzmann DR, Moseley ME. 1995. Navigated diffusion imaging of normal and ischemic human brain. Magn Reson Imaging 33:720-728.
31. De Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA. 2000. From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann N Y Acad Sci 911:240-253.
32. Defranceso M, Schocke M, Messner HJ, Deisenhammer EA, Hinterhuber H, Marksteiner J, Weiss EM. 2010. [Conversion from MCI (mild cognitive impairment) to Alzheimer's disease: diagnostic options and predictors]. Neuropsychiatry 24:88-98.
33. Dejerine J, Dejerine-Klumpke M. 1901. Anatomie des centres nerveux. Anatomie du cerveau-anatomie du rhombencephale. Paris: J. Rueff, Editeur.
34. Diniz BS, Pinto Junior JA, Forlenza OV. 2008. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry 9:172-182.
35. Drago V, Babiloni C, Bartres-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hardemark HG, Frisoni GB. 2011. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. J Alzheimers Dis 26 Suppl 3:159-199.
36. 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Acta Neuropathol 124:823-831.
37. Duvernoy HM. 1988. The human hippocampus: an atlas of applied anatomy. Munchen: J.F. Bergmann Verlag.
38. Duyckaerts C, Delatour B, Potier MC. 2009. Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5-36.
39. Ewers M, Frisoni GB, Teipel SJ, Grinberg LT, Amaro E Jr, Heinsen H, Thompson PM, Hampel H. 2011. Staging Alzheimer's disease progression with multimodality neuroimaging. Prog Neurobiol 95:535-546.
40. Falini A, Bozzali M, Magnani G, Pero G, Gambini A, Benedetti B, Mossini R, Franceschi M, Comi G, Scotti G, Filippi M. 2005. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment. Neuroimage 26:1159-1163.
41. Fellgiebel A, Yakushev I. 2011. Diffusion tensor imaging of the hippocampus in MCI and early Alzheimer's disease. J Alzheimers Dis 26(Suppl 3):257-262.
42. Fellgiebel A, Wille P, Muller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P. 2004. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 18:101-108.
43. Fellgiebel A, Dellani PR, Greverus D, Scheurich A, Stoeter P, Muller MJ. 2006. Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatr Res 146:283-287.
44. Filler AG, Bell BA. 1992. Axonal transport, imaging, and the diagnosis of nerve compression. Br J Neurosurg 6:293-295.
45. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH. 2007. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology 68:288-291.
46. Fox NC, Schott JM. 2004. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet 363:392-394.
47. Fraley C, Raftery AE. 2007. Model-based methods of classification: using the mclust software in cehmometrics. J Statist Software 18(6).
48. 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography. Mol Imaging Biol (in press).
49. Geslani DM, Tierney MC, Herrmann N, Szalai JP. 2005. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord 19:383-389.
50. Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR. 2003. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60:1495-1500.
51. Gold BT, Johnson NF, Powell DK, Smith CD. 2012. White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions. Biochim Biophys Acta 1822:416-422.
52. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. 1996. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16:4491-4500.
53. Gomez-Isla T, Spires T, De Calignon A, Hyman BT. 2008. Neuropathology of Alzheimer's disease. Hdbk Clin Neurol 89:233-243.
54. Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K. 2008. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 4:38-48.
55. Insausti R. 1993. Comparative anatomy of the entorhinal cortex and hippocampus in mammals. Hippocampus 3(Spec. No.):19-26.
56. Insausti R, Amaral DG, Cowan WM. 1987a. The entorhinal cortex of the monkey: II. Cortical afferents. J Comp Neurol 264:356-395.
57. Insausti R, Amaral DG, Cowan WM. 1987b. The entorhinal cortex of the monkey: III. Subcortical afferents. J Comp Neurol 264:396-408.
58. Insausti R, Tunon T, Sobreviela T, Insausti AM, Gonzalo LM. 1995. The human entorhinal cortex: a cytoarchitectonic analysis. J Comp Neurol 355:171-198.
59. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC. 2004. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62:591-600.
60. Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW. 2010. Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 6:212-220.
61. Jensen JR, Cisek K, Funk KE, Naphade S, Schafer KN, Kuret J. 2011. Research towards tau imaging. J Alzheimers Dis 26(Suppl 3):147-157.
62. Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Wiest R, Nyffeler T, Buri C, Federspiel A, Kunz D, Schroth G, Kiefer C. 2006. Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage 30:713-720.
63. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, Shiung MM, Smith GE, Ivnik RJ, Tangalos EG, Jack CR Jr. 2005. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64:902-904.
64. Kaplan E, Goodglass J, Weintraub S. 1983. Boston Naming Test. Philadelphia: Lea and Febiger.
65. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman BT, Albert MS. 2000. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 47:430-439.
66. Kunimatsu A, Aoki S, Masutani Y, Abe O, Mori H, Ohtomo K. 2003. Three-dimensional white matter tractography by diffusion tensor imaging in ischaemic stroke involving the corticospinal tract. Neuroradiology 45:532-535.
67. Lavenex P, Suzuki WA, Amaral DG. 2002. Perirhinal and parahippocampal cortices of the macaque monkey: projections to the neocortex. J Comp Neurol 447:394-420.
68. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H. 2001. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13:534-546.
69. Lehrner J, Gufler R, Guttmann G, Maly J, Gleiss A, Auff E, Dal-Bianco P. 2005. Annual conversion to Alzheimer'sdisease among patients with memory complaints attending an outpatient memory clinic: the influence of amnestic mild cognitive impairment and the predictive value of neuropsychological testing. Wien Klin Wochenschrift 117:629-635.
70. Liu Y, Spulber G, Lehtimaki KK, Kononen M, Hallikainen I, Grohn H, Kivipelto M, Hallikainen M, Vanninen R, Soininen H. 2009. Diffusion tensor imaging and tract-based spatial statistics in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging.
71. Matthews PM, Filippini N, Douaud G. 2013. Brain structural and functional connectivity and the progression of neuropathology in Alzheimer's disease. J Alzheimers Dis 33(Suppl 1):S163-S172.
72. McEvoy LK, Holland D, Hagler DJ Jr, Fennema-Notestine C, Brewer JB, Dale AM, Alzheimer's Disease Neuroimaging. 2011. Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis. Radiology 259:834-843.
73. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. 2011. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263-269.
74. Misra C, Fan Y, Davatzikos C. 2009. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 44:1415-1422.
75. Mitchell AJ. 2009. CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies. J Neurol Neurosurg Psychiatry 80:966-975.
76. Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, Han LY, Bienias JL, Lee VM, Trojanowski JQ, Bennett DA, Arnold SE. 2002. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol 51:182-189.
77. Modrego PJ. 2006. Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment. Curr Alzheimer Res 3:161-170.
78. Mohedano-Moriano A, Pro-Sistiaga P, Arroyo-Jimenez MM, Artacho-Perula E, Insausti AM, Marcos P, Cebada-Sanchez S, Martinez-Ruiz J, Munoz M, Blaizot X, Martinez-Marcos A, Amaral DG, Insausti R. 2007. Topographical and laminar distribution of cortical input to the monkey entorhinal cortex. J Anat 211:250-260.
79. Mori S, Frederiksen K, van Zijl PC, Stieltjes B, Kraut MA, Solaiyappan M, Pomper MG. 2002. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 51:377-380.
80. Morris JC. 2005. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics Suppl:9-14.
81. Mortimer JA, Petersen RC. 2008. Detection of prodromal Alzheimer's disease. Ann Neurol 64:479-480.
82. Mosconi L. 2005. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486-510.
83. Muller MJ, Greverus D, Dellani PR, Weibrich C, Wille PR, Scheurich A, Stoeter P, Fellgiebel A. 2005. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 28:1033-1042.
84. Nagy Z, Hindley NJ, Braak H, Braak E, Yilmazer-Hanke DM, Schultz C, Barnetson L, King EM, Jobst KA, Smith AD. 1999. The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord 10:115-120.
85. Oishi K, Mielke MM, Albert M, Lyketsos CG, Mori S. 2011. DTI analyses and clinical applications in Alzheimer's disease. J Alzheimers Dis 26(Suppl 3):287-296.
86. 18F, a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease. IDrugs 13:890-899.
87. Ono M. 2009. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains. Chem Pharm Bull (Tokyo) 57:1029-1039.
88. Pavlovic DM, Pavlovic AM. 2009. [Mild cognitive impairment]. Srp Arh Celok Lek 137:434-439.
89. Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala EL, Hanninen T, Kivipelto M, Kononen M, Nissinen A, Tervo S, Vanhanen M, Vanninen R, Frisoni GB, Soininen H. 2005. A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 76:11-14.
90. Petersen RC. 2004. Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183-194.
91. Petersen RC, Negash S. 2008. Mild cognitive impairment: an overview. CNS Spectr 13:45-53.
92. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. 1996. Diffusion tensor MR imaging of the human brain. Radiology 201:637-648.
93. Reitan RM. 1958. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 8:271-276.
94. Rogalski EJ, Murphy CM, deToledo-Morrell L, Shah RC, Moseley ME, Bammer R, Stebbins GT. 2009. Changes in parahippocampal white matter integrity in amnestic mild cognitive impairment: a diffusion tensor imaging study. Behav Neurol 21:51-61.
95. Rose SE, Chen F, Chalk JB, Zelaya FO, Strugnell WE, Benson M, Semple J, Doddrell DM. 2000. Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 69:528-530.
96. Rose SE, McMahon KL, Janke AL, O'Dowd B, de Zubicaray G, Strudwick MW, Chalk JB. 2006. Diffusion indices on magnetic resonance imaging and neuropsychological performance in amnestic mild cognitive impairment. J Neurol Neurosurg Psychiatry 77:1122-1128.
97. Rosene DL, Van Hoesen GW. 1977. Hippocampal efferents reach widespread areas of cerebral cortex and amygdala in the rhesus monkey. Science 198:315-317.
98. Sassin I, Schultz C, Thal DR, Rub U, Arai K, Braak E, Braak H. 2000. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol 100:259-269.
99. Schwarz G. 1978. Estimating the dimensions of a model. Ann Statist 6:461-464.
100. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. 2010. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 32:5-18.
101. Shapiro AM, Benedict RH, Schretlen D, Brandt J. 1999. Construct and concurrent validity of the Hopkins Verbal Learning Test revised. Clin Neuropsychol 13:348-358.
102. Shin J, Kepe V, Barrio JR, Small GW. 2011. The merits of FDDNP-PET imaging in Alzheimer's disease. J Alzheimers Dis 26(Suppl 3):135-145.
103. Small GW. 2002. Brain-imaging surrogate markers for detection and prevention of age-related memory loss. J Mol Neurosci 19:17-21.
104. Small GW, Agdeppa ED, Kepe V, Satyamurthy N, Huang SC, Barrio JR. 2002. In vivo brain imaging of tangle burden in humans. J Mol Neurosci 19:323-327.
105. Solodkin A, Hlustik P, Chen EE, Small SL. 2004. Fine modulation in network activation during motor execution and motor imagery. Cereb Cortex 14:1246-1255.
106. Spreen O, Strauss E. 1998. Controlled oral word association. A compendium of neuropsychological tests, 2nd ed. New York: Oxford University Press. p 447-464.
107. Sprooten E, Lymer GK, Munoz Maniega S, McKirdy J, Clayden JD, Bastin ME, Porteous D, Johnstone EC, Lawrie SM, Hall J, McIntosh AM. 2009. The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants. Mol Psychiatry 14:237-238, 233.
108. Stebbins GT, Murphy CM. 2009. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol 21:39-49.
109. Stenset V, Bjornerud A, Fjell AM, Walhovd KB, Hofoss D, Due-Tonnessen P, Gjerstad L, Fladby T. 2009. Cingulum fiber diffusivity and CSF T-tau in patients with subjective and mild cognitive impairment. Neurobiol Aging 32:581-589.
110. Stepan-Buksakowska I, Keller J, Laczo J, Rulseh A, Hort J, Lisy J, Charvat F, Rocek M, Horinek D. 2012. Diffusion tensor imaging in Alzheimer disease and mild cognitive impairment. Neurol Neurochir Pol 46:462-471.
111. Suva D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J. 1999. Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58:1125-1134.
112. Teipel SJ, Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein KH, Filippi M, Ernemann U, Reiser MF, Hampel H. 2010. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 22:507-522.
113. Trojanowski JQ. 2002. Tauists, Baptists, Syners, Apostates, and new data. Ann Neurol 52:263-265.
114. Valls-Pedret C, Molinuevo JL, Rami L. 2010. [Early diagnosis of Alzheimer's disease: the prodromal and preclinical phase]. Rev Neurol 51:471-480.
115. Van Hoesen GW. 1982. The parahippocampal gyrus: new observations regarding its cortical connections in the monkey. Trends Neurosci 5:345-350.
116. Van Hoesen GW. 1995. Anatomy of the medial temporal lobe. Magn Reson Imaging 13:1047-1055.
117. Van Hoesen GW, Pandya DN. 1975. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections. Brain Res 95:39-59.
118. Van Hoesen GW, Solodkin A. 1993. Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cereb Cortex 3:465-475.
119. Van Hoesen GW, Solodkin A. 1994. Cellular and system neuroanatomical changes in Alzheimer's disease. Ann N Y Acad Sci 747:12-35.
120. Van Hoesen GW, Hyman BT, Damasio AR. 1991. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1:1-8.
121. Van Hoesen GW, Augustinack JC, Dierking J, Redman SJ, Thangavel R. 2000. The parahippocampal gyrus in Alzheimer's disease. Clinical and preclinical neuroanatomical correlates. Ann N Y Acad Sci 911:254-274.
122. van Rossum IA, Vos S, Handels R, Visser PJ. 2010. Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design. J Alzheimers Dis 20:881-891.
123. Wilkinson GS. 1993. The Wide Range Achievement Test-III. Wimnington, DE: Jastack Associates, A division of Wide Range Inc.
124. Wippold FJ 2nd, Cairns N, Vo K, Holtzman DM, Morris JC. 2008. Neuropathology for the neuroradiologist: plaques and tangles. AJNR Am J Neuroradiol 29:18-22.
125. Witter MP. 2007. The perforant path: projections from the entorhinal cortex to the dentate gyrus. Prog Brain Res 163:43-61.
126. Woods R, Grafton S, Holmes C, Cherry S, Mazziotta J. 1998. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:141-154.
127. Yassa MA, Muftuler LT, Stark CE. 2010. Ultrahigh-resolution microstructural diffusion tensor imaging reveals perforant path degradation in aged humans in vivo. Proc Natl Acad Sci U S A 107:12687-12691.
128. Yesavage JA, Brink TL, Rose TL, Adey M. 1983. The Geriatric Depression Rating Scale: comparison with other self-report and psychiatric rating scales. In: Crook T, editor. Assessment in geriatric psychopharmacology. New Canaan, CT: Mark Powley Associates. p 153-167.
129. Zeineh MM, Holdsworth S, Skare S, Atlas SW, Bammer R. 2012. Ultra-high resolution diffusion tensor imaging of the microscopic pathways of the medial temporal lobe. Neuroimage 62:2065-2082.